nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0313	0.0458	CbGbCtD
Paclitaxel—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.027	0.0395	CbGbCtD
Paclitaxel—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0237	0.0347	CbGbCtD
Paclitaxel—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0237	0.0347	CbGbCtD
Paclitaxel—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.02	0.0293	CbGbCtD
Paclitaxel—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0176	0.0257	CbGbCtD
Paclitaxel—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0176	0.0257	CbGbCtD
Paclitaxel—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0176	0.0257	CbGbCtD
Paclitaxel—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0257	CbGbCtD
Paclitaxel—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0232	CbGbCtD
Paclitaxel—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0232	CbGbCtD
Paclitaxel—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0155	0.0226	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0155	0.0226	CbGbCtD
Paclitaxel—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0152	0.0223	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0195	CbGbCtD
Paclitaxel—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0195	CbGbCtD
Paclitaxel—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.013	0.019	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.019	CbGbCtD
Paclitaxel—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.019	CbGbCtD
Paclitaxel—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0128	0.0188	CbGbCtD
Paclitaxel—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0118	0.0172	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0171	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0171	CbGbCtD
Paclitaxel—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0171	CbGbCtD
Paclitaxel—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0171	CbGbCtD
Paclitaxel—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0116	0.017	CbGbCtD
Paclitaxel—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0116	0.017	CbGbCtD
Paclitaxel—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0112	0.0163	CbGbCtD
Paclitaxel—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0112	0.0163	CbGbCtD
Paclitaxel—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.01	0.0147	CbGbCtD
Paclitaxel—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00973	0.0142	CbGbCtD
Paclitaxel—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00916	0.0134	CbGbCtD
Paclitaxel—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0088	0.0129	CbGbCtD
Paclitaxel—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0088	0.0129	CbGbCtD
Paclitaxel—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00861	0.0126	CbGbCtD
Paclitaxel—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00861	0.0126	CbGbCtD
Paclitaxel—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00846	0.0124	CbGbCtD
Paclitaxel—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00846	0.0124	CbGbCtD
Paclitaxel—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00836	0.0122	CbGbCtD
Paclitaxel—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00811	0.0119	CbGbCtD
Paclitaxel—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00779	0.0114	CbGbCtD
Paclitaxel—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00779	0.0114	CbGbCtD
Paclitaxel—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00756	0.011	CbGbCtD
Paclitaxel—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00672	0.00983	CbGbCtD
Paclitaxel—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00652	0.00954	CbGbCtD
Paclitaxel—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00652	0.00954	CbGbCtD
Paclitaxel—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00633	0.00926	CbGbCtD
Paclitaxel—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0059	0.00863	CbGbCtD
Paclitaxel—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0059	0.00863	CbGbCtD
Paclitaxel—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00573	0.00837	CbGbCtD
Paclitaxel—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00573	0.00837	CbGbCtD
Paclitaxel—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00566	0.00827	CbGbCtD
Paclitaxel—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00549	0.00803	CbGbCtD
Paclitaxel—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00532	0.00778	CbGbCtD
Paclitaxel—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00501	0.00732	CbGbCtD
Paclitaxel—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00501	0.00732	CbGbCtD
Paclitaxel—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00453	0.00662	CbGbCtD
Paclitaxel—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00453	0.00662	CbGbCtD
Paclitaxel—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00425	0.00621	CbGbCtD
Paclitaxel—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00391	0.00571	CbGbCtD
Paclitaxel—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00379	0.00555	CbGbCtD
Paclitaxel—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00343	0.00502	CbGbCtD
Paclitaxel—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00343	0.00502	CbGbCtD
Paclitaxel—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00329	0.00481	CbGbCtD
Paclitaxel—CYP19A1—semen—acquired immunodeficiency syndrome	0.00222	0.0268	CbGeAlD
Paclitaxel—MAP2—nerve—acquired immunodeficiency syndrome	0.0021	0.0253	CbGeAlD
Paclitaxel—MAP4—blood plasma—acquired immunodeficiency syndrome	0.00201	0.0243	CbGeAlD
Paclitaxel—TUBB1—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0237	CbGeAlD
Paclitaxel—TUBB6—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.00176	0.656	CbGdCrCtD
Paclitaxel—MAPT—retina—acquired immunodeficiency syndrome	0.0014	0.0169	CbGeAlD
Paclitaxel—NR1I2—digestive system—acquired immunodeficiency syndrome	0.00118	0.0143	CbGeAlD
Paclitaxel—MAP4—retina—acquired immunodeficiency syndrome	0.0011	0.0133	CbGeAlD
Paclitaxel—MAP4—skin of body—acquired immunodeficiency syndrome	0.000968	0.0117	CbGeAlD
Paclitaxel—TUBB6—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000924	0.344	CbGdCrCtD
Paclitaxel—MAPT—spinal cord—acquired immunodeficiency syndrome	0.000904	0.0109	CbGeAlD
Paclitaxel—BCL2—skin of body—acquired immunodeficiency syndrome	0.00088	0.0106	CbGeAlD
Paclitaxel—TUBB8—nervous system—acquired immunodeficiency syndrome	0.000878	0.0106	CbGeAlD
Paclitaxel—MAP2—retina—acquired immunodeficiency syndrome	0.000868	0.0105	CbGeAlD
Paclitaxel—TUBB8—central nervous system—acquired immunodeficiency syndrome	0.000845	0.0102	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—acquired immunodeficiency syndrome	0.000784	0.00945	CbGeAlD
Paclitaxel—TUBB3—lymphoid tissue—acquired immunodeficiency syndrome	0.000784	0.00945	CbGeAlD
Paclitaxel—TUBB3—digestive system—acquired immunodeficiency syndrome	0.000774	0.00934	CbGeAlD
Paclitaxel—MAP4—digestive system—acquired immunodeficiency syndrome	0.000774	0.00934	CbGeAlD
Paclitaxel—TUBB3—blood—acquired immunodeficiency syndrome	0.000738	0.00889	CbGeAlD
Paclitaxel—MAP4—blood—acquired immunodeficiency syndrome	0.000738	0.00889	CbGeAlD
Paclitaxel—TUBB1—blood—acquired immunodeficiency syndrome	0.000721	0.0087	CbGeAlD
Paclitaxel—BCL2—lymphoid tissue—acquired immunodeficiency syndrome	0.000713	0.00859	CbGeAlD
Paclitaxel—MAP4—spinal cord—acquired immunodeficiency syndrome	0.000711	0.00857	CbGeAlD
Paclitaxel—BCL2—digestive system—acquired immunodeficiency syndrome	0.000704	0.00849	CbGeAlD
Paclitaxel—TUBB1—bone marrow—acquired immunodeficiency syndrome	0.000698	0.00841	CbGeAlD
Paclitaxel—TUBB8—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000685	0.0687	CbGpPWpGaD
Paclitaxel—MAP4—vagina—acquired immunodeficiency syndrome	0.000684	0.00824	CbGeAlD
Paclitaxel—TUBB4A—retina—acquired immunodeficiency syndrome	0.000671	0.00809	CbGeAlD
Paclitaxel—TUBB8—brain—acquired immunodeficiency syndrome	0.000671	0.00809	CbGeAlD
Paclitaxel—BCL2—blood—acquired immunodeficiency syndrome	0.000671	0.00808	CbGeAlD
Paclitaxel—BCL2—bone marrow—acquired immunodeficiency syndrome	0.000649	0.00782	CbGeAlD
Paclitaxel—TUBB2B—retina—acquired immunodeficiency syndrome	0.000649	0.00782	CbGeAlD
Paclitaxel—TUBB3—lung—acquired immunodeficiency syndrome	0.000647	0.0078	CbGeAlD
Paclitaxel—MAP4—lung—acquired immunodeficiency syndrome	0.000647	0.0078	CbGeAlD
Paclitaxel—MAP2—digestive system—acquired immunodeficiency syndrome	0.00061	0.00735	CbGeAlD
Paclitaxel—TUBB3—nervous system—acquired immunodeficiency syndrome	0.000599	0.00722	CbGeAlD
Paclitaxel—MAP4—nervous system—acquired immunodeficiency syndrome	0.000599	0.00722	CbGeAlD
Paclitaxel—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000599	0.00722	CbGeAlD
Paclitaxel—TUBB4A—skin of body—acquired immunodeficiency syndrome	0.000589	0.0071	CbGeAlD
Paclitaxel—BCL2—lung—acquired immunodeficiency syndrome	0.000588	0.00709	CbGeAlD
Paclitaxel—TUBB1—nervous system—acquired immunodeficiency syndrome	0.000586	0.00706	CbGeAlD
Paclitaxel—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000585	0.00705	CbGeAlD
Paclitaxel—MAPT—brain—acquired immunodeficiency syndrome	0.000582	0.00702	CbGeAlD
Paclitaxel—MAP2—blood—acquired immunodeficiency syndrome	0.000581	0.007	CbGeAlD
Paclitaxel—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00058	0.00699	CbGeAlD
Paclitaxel—MAP4—central nervous system—acquired immunodeficiency syndrome	0.000577	0.00695	CbGeAlD
Paclitaxel—TUBB3—central nervous system—acquired immunodeficiency syndrome	0.000577	0.00695	CbGeAlD
Paclitaxel—SLCO1B3—lung—acquired immunodeficiency syndrome	0.000566	0.00683	CbGeAlD
Paclitaxel—TUBB1—central nervous system—acquired immunodeficiency syndrome	0.000564	0.0068	CbGeAlD
Paclitaxel—MAPT—lymph node—acquired immunodeficiency syndrome	0.000563	0.00678	CbGeAlD
Paclitaxel—MAP2—spinal cord—acquired immunodeficiency syndrome	0.00056	0.00675	CbGeAlD
Paclitaxel—BCL2—nervous system—acquired immunodeficiency syndrome	0.000544	0.00656	CbGeAlD
Paclitaxel—MAP2—vagina—acquired immunodeficiency syndrome	0.000539	0.00649	CbGeAlD
Paclitaxel—TUBB2A—skin of body—acquired immunodeficiency syndrome	0.000536	0.00646	CbGeAlD
Paclitaxel—TUBB6—skin of body—acquired immunodeficiency syndrome	0.000529	0.00637	CbGeAlD
Paclitaxel—BCL2—central nervous system—acquired immunodeficiency syndrome	0.000524	0.00632	CbGeAlD
Paclitaxel—TUBB4B—retina—acquired immunodeficiency syndrome	0.000523	0.00631	CbGeAlD
Paclitaxel—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000523	0.00631	CbGeAlD
Paclitaxel—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000515	0.00621	CbGeAlD
Paclitaxel—MAP2—lung—acquired immunodeficiency syndrome	0.000509	0.00614	CbGeAlD
Paclitaxel—TUBB4A—lymphoid tissue—acquired immunodeficiency syndrome	0.000477	0.00575	CbGeAlD
Paclitaxel—MAP2—nervous system—acquired immunodeficiency syndrome	0.000472	0.00569	CbGeAlD
Paclitaxel—TUBB4A—digestive system—acquired immunodeficiency syndrome	0.000471	0.00568	CbGeAlD
Paclitaxel—TUBB4B—skin of body—acquired immunodeficiency syndrome	0.00046	0.00554	CbGeAlD
Paclitaxel—TUBB3—brain—acquired immunodeficiency syndrome	0.000458	0.00552	CbGeAlD
Paclitaxel—MAP4—brain—acquired immunodeficiency syndrome	0.000458	0.00552	CbGeAlD
Paclitaxel—TUBB2B—digestive system—acquired immunodeficiency syndrome	0.000455	0.00549	CbGeAlD
Paclitaxel—MAP2—central nervous system—acquired immunodeficiency syndrome	0.000454	0.00547	CbGeAlD
Paclitaxel—TUBB4A—blood—acquired immunodeficiency syndrome	0.000449	0.00541	CbGeAlD
Paclitaxel—TUBB1—brain—acquired immunodeficiency syndrome	0.000448	0.0054	CbGeAlD
Paclitaxel—MAP4—lymph node—acquired immunodeficiency syndrome	0.000442	0.00533	CbGeAlD
Paclitaxel—TUBB4A—spinal cord—acquired immunodeficiency syndrome	0.000433	0.00521	CbGeAlD
Paclitaxel—TUBB2A—digestive system—acquired immunodeficiency syndrome	0.000429	0.00517	CbGeAlD
Paclitaxel—TUBB6—lymphoid tissue—acquired immunodeficiency syndrome	0.000428	0.00516	CbGeAlD
Paclitaxel—TUBB6—digestive system—acquired immunodeficiency syndrome	0.000423	0.0051	CbGeAlD
Paclitaxel—TUBB2B—spinal cord—acquired immunodeficiency syndrome	0.000418	0.00504	CbGeAlD
Paclitaxel—BCL2—brain—acquired immunodeficiency syndrome	0.000416	0.00502	CbGeAlD
Paclitaxel—TUBB—blood—acquired immunodeficiency syndrome	0.000411	0.00495	CbGeAlD
Paclitaxel—TUBB2A—blood—acquired immunodeficiency syndrome	0.000408	0.00492	CbGeAlD
Paclitaxel—TUBB6—blood—acquired immunodeficiency syndrome	0.000403	0.00486	CbGeAlD
Paclitaxel—TUBB2B—vagina—acquired immunodeficiency syndrome	0.000402	0.00485	CbGeAlD
Paclitaxel—BCL2—lymph node—acquired immunodeficiency syndrome	0.000402	0.00485	CbGeAlD
Paclitaxel—TUBB—bone marrow—acquired immunodeficiency syndrome	0.000397	0.00479	CbGeAlD
Paclitaxel—TUBB—spinal cord—acquired immunodeficiency syndrome	0.000396	0.00477	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—acquired immunodeficiency syndrome	0.000395	0.00476	CbGeAlD
Paclitaxel—TUBB4A—lung—acquired immunodeficiency syndrome	0.000394	0.00474	CbGeAlD
Paclitaxel—TUBB2A—spinal cord—acquired immunodeficiency syndrome	0.000394	0.00474	CbGeAlD
Paclitaxel—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000393	0.00473	CbGeAlD
Paclitaxel—TUBB6—bone marrow—acquired immunodeficiency syndrome	0.00039	0.0047	CbGeAlD
Paclitaxel—TUBB6—spinal cord—acquired immunodeficiency syndrome	0.000388	0.00468	CbGeAlD
Paclitaxel—TUBB—vagina—acquired immunodeficiency syndrome	0.000381	0.00459	CbGeAlD
Paclitaxel—TUBB2B—lung—acquired immunodeficiency syndrome	0.00038	0.00459	CbGeAlD
Paclitaxel—TUBB2A—vagina—acquired immunodeficiency syndrome	0.000379	0.00456	CbGeAlD
Paclitaxel—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000375	0.00452	CbGeAlD
Paclitaxel—TUBB6—vagina—acquired immunodeficiency syndrome	0.000373	0.0045	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—acquired immunodeficiency syndrome	0.000372	0.00449	CbGeAlD
Paclitaxel—ABCC10—digestive system—acquired immunodeficiency syndrome	0.00037	0.00446	CbGeAlD
Paclitaxel—TUBB4B—digestive system—acquired immunodeficiency syndrome	0.000368	0.00443	CbGeAlD
Paclitaxel—TUBB4A—nervous system—acquired immunodeficiency syndrome	0.000364	0.00439	CbGeAlD
Paclitaxel—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000364	0.00439	CbGeAlD
Paclitaxel—MAP2—brain—acquired immunodeficiency syndrome	0.00036	0.00435	CbGeAlD
Paclitaxel—TUBB—lung—acquired immunodeficiency syndrome	0.00036	0.00434	CbGeAlD
Paclitaxel—TUBB2A—lung—acquired immunodeficiency syndrome	0.000358	0.00432	CbGeAlD
Paclitaxel—TUBB6—lung—acquired immunodeficiency syndrome	0.000353	0.00426	CbGeAlD
Paclitaxel—ABCC10—blood—acquired immunodeficiency syndrome	0.000353	0.00425	CbGeAlD
Paclitaxel—TUBB2B—nervous system—acquired immunodeficiency syndrome	0.000352	0.00425	CbGeAlD
Paclitaxel—TUBB4A—central nervous system—acquired immunodeficiency syndrome	0.000351	0.00423	CbGeAlD
Paclitaxel—TUBB4B—blood—acquired immunodeficiency syndrome	0.00035	0.00422	CbGeAlD
Paclitaxel—MAP2—lymph node—acquired immunodeficiency syndrome	0.000348	0.0042	CbGeAlD
Paclitaxel—TUBB2B—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000346	0.0348	CbGpPWpGaD
Paclitaxel—TUBB6—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000346	0.0348	CbGpPWpGaD
Paclitaxel—TUBB—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000343	0.0344	CbGpPWpGaD
Paclitaxel—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000341	0.00411	CbGeAlD
Paclitaxel—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.00034	0.0041	CbGeAlD
Paclitaxel—TUBB2B—central nervous system—acquired immunodeficiency syndrome	0.000339	0.00409	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—acquired immunodeficiency syndrome	0.000339	0.00408	CbGeAlD
Paclitaxel—TUBB4B—spinal cord—acquired immunodeficiency syndrome	0.000337	0.00407	CbGeAlD
Paclitaxel—TUBB3—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000335	0.0336	CbGpPWpGaD
Paclitaxel—TUBB2A—nervous system—acquired immunodeficiency syndrome	0.000332	0.004	CbGeAlD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—ACTG1—acquired immunodeficiency syndrome	0.000329	0.033	CbGpPWpGaD
Paclitaxel—TUBB6—nervous system—acquired immunodeficiency syndrome	0.000327	0.00394	CbGeAlD
Paclitaxel—ABCC10—vagina—acquired immunodeficiency syndrome	0.000327	0.00394	CbGeAlD
Paclitaxel—TUBB4B—vagina—acquired immunodeficiency syndrome	0.000325	0.00391	CbGeAlD
Paclitaxel—TUBB2A—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000324	0.0325	CbGpPWpGaD
Paclitaxel—TUBB2A—central nervous system—acquired immunodeficiency syndrome	0.000319	0.00385	CbGeAlD
Paclitaxel—TUBB1—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000317	0.0318	CbGpPWpGaD
Paclitaxel—TUBB6—central nervous system—acquired immunodeficiency syndrome	0.000315	0.0038	CbGeAlD
Paclitaxel—ABCC10—lung—acquired immunodeficiency syndrome	0.000309	0.00373	CbGeAlD
Paclitaxel—TUBB4B—lung—acquired immunodeficiency syndrome	0.000307	0.0037	CbGeAlD
Paclitaxel—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000297	0.00358	CbGeAlD
Paclitaxel—CYP19A1—blood—acquired immunodeficiency syndrome	0.000297	0.00358	CbGeAlD
Paclitaxel—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000295	0.00355	CbGeAlD
Paclitaxel—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000291	0.00351	CbGeAlD
Paclitaxel—TUBB4A—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000284	0.0285	CbGpPWpGaD
Paclitaxel—TUBB4B—nervous system—acquired immunodeficiency syndrome	0.000284	0.00343	CbGeAlD
Paclitaxel—ABCC2—blood—acquired immunodeficiency syndrome	0.000283	0.00341	CbGeAlD
Paclitaxel—TUBB4A—brain—acquired immunodeficiency syndrome	0.000279	0.00336	CbGeAlD
Paclitaxel—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000278	0.00335	CbGeAlD
Paclitaxel—CYP1B1—blood—acquired immunodeficiency syndrome	0.000277	0.00334	CbGeAlD
Paclitaxel—TUBB4B—central nervous system—acquired immunodeficiency syndrome	0.000274	0.0033	CbGeAlD
Paclitaxel—TUBB2B—brain—acquired immunodeficiency syndrome	0.000269	0.00325	CbGeAlD
Paclitaxel—TUBB4A—lymph node—acquired immunodeficiency syndrome	0.000269	0.00324	CbGeAlD
Paclitaxel—TUBB4B—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.00026	0.0261	CbGpPWpGaD
Paclitaxel—TUBB2B—lymph node—acquired immunodeficiency syndrome	0.00026	0.00314	CbGeAlD
Paclitaxel—TUBB—brain—acquired immunodeficiency syndrome	0.000255	0.00307	CbGeAlD
Paclitaxel—TUBB2A—brain—acquired immunodeficiency syndrome	0.000253	0.00306	CbGeAlD
Paclitaxel—SLCO1B3—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000252	0.0253	CbGpPWpGaD
Paclitaxel—TUBB6—brain—acquired immunodeficiency syndrome	0.00025	0.00301	CbGeAlD
Paclitaxel—ABCC1—blood—acquired immunodeficiency syndrome	0.000249	0.00301	CbGeAlD
Paclitaxel—TUBB—lymph node—acquired immunodeficiency syndrome	0.000246	0.00297	CbGeAlD
Paclitaxel—TUBB2A—lymph node—acquired immunodeficiency syndrome	0.000245	0.00295	CbGeAlD
Paclitaxel—CYP1B1—lung—acquired immunodeficiency syndrome	0.000243	0.00293	CbGeAlD
Paclitaxel—TUBB6—lymph node—acquired immunodeficiency syndrome	0.000242	0.00291	CbGeAlD
Paclitaxel—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000241	0.0029	CbGeAlD
Paclitaxel—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000232	0.0028	CbGeAlD
Paclitaxel—ABCC1—vagina—acquired immunodeficiency syndrome	0.000231	0.00279	CbGeAlD
Paclitaxel—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000225	0.00271	CbGeAlD
Paclitaxel—ABCC10—brain—acquired immunodeficiency syndrome	0.000219	0.00264	CbGeAlD
Paclitaxel—ABCC1—lung—acquired immunodeficiency syndrome	0.000219	0.00264	CbGeAlD
Paclitaxel—TUBB4B—brain—acquired immunodeficiency syndrome	0.000217	0.00262	CbGeAlD
Paclitaxel—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000217	0.00261	CbGeAlD
Paclitaxel—CYP2C8—blood—acquired immunodeficiency syndrome	0.000212	0.00256	CbGeAlD
Paclitaxel—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000211	0.00255	CbGeAlD
Paclitaxel—TUBB4B—lymph node—acquired immunodeficiency syndrome	0.00021	0.00253	CbGeAlD
Paclitaxel—ABCG2—blood—acquired immunodeficiency syndrome	0.000207	0.00249	CbGeAlD
Paclitaxel—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000201	0.00243	CbGeAlD
Paclitaxel—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.0002	0.00241	CbGeAlD
Paclitaxel—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000199	0.0024	CbGeAlD
Paclitaxel—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000198	0.00239	CbGeAlD
Paclitaxel—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000197	0.00237	CbGeAlD
Paclitaxel—BCL2—IL2 signaling events mediated by STAT5—IL4—acquired immunodeficiency syndrome	0.000192	0.0193	CbGpPWpGaD
Paclitaxel—CYP3A5—blood—acquired immunodeficiency syndrome	0.000192	0.00231	CbGeAlD
Paclitaxel—ABCG2—vagina—acquired immunodeficiency syndrome	0.000191	0.00231	CbGeAlD
Paclitaxel—CYP2C9—blood—acquired immunodeficiency syndrome	0.000189	0.00227	CbGeAlD
Paclitaxel—SLCO1B3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000187	0.0187	CbGpPWpGaD
Paclitaxel—CYP19A1—brain—acquired immunodeficiency syndrome	0.000184	0.00222	CbGeAlD
Paclitaxel—ABCG2—lung—acquired immunodeficiency syndrome	0.000181	0.00218	CbGeAlD
Paclitaxel—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000178	0.00214	CbGeAlD
Paclitaxel—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000178	0.00214	CbGeAlD
Paclitaxel—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000176	0.0176	CbGpPWpGaD
Paclitaxel—CYP1B1—brain—acquired immunodeficiency syndrome	0.000172	0.00207	CbGeAlD
Paclitaxel—ABCC2—lymph node—acquired immunodeficiency syndrome	0.00017	0.00205	CbGeAlD
Paclitaxel—CYP3A5—lung—acquired immunodeficiency syndrome	0.000168	0.00203	CbGeAlD
Paclitaxel—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000166	0.002	CbGeAlD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00016	0.0161	CbGpPWpGaD
Paclitaxel—ABCC1—brain—acquired immunodeficiency syndrome	0.000155	0.00187	CbGeAlD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000153	0.0154	CbGpPWpGaD
Paclitaxel—ABCB1—retina—acquired immunodeficiency syndrome	0.000152	0.00184	CbGeAlD
Paclitaxel—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000151	0.00182	CbGeAlD
Paclitaxel—ABCC1—lymph node—acquired immunodeficiency syndrome	0.00015	0.0018	CbGeAlD
Paclitaxel—CYP3A4—blood—acquired immunodeficiency syndrome	0.000144	0.00173	CbGeAlD
Paclitaxel—MAPT—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000133	0.0134	CbGpPWpGaD
Paclitaxel—CYP2C8—brain—acquired immunodeficiency syndrome	0.000132	0.00159	CbGeAlD
Paclitaxel—MAPT—IL-2 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000128	0.0129	CbGpPWpGaD
Paclitaxel—ABCG2—brain—acquired immunodeficiency syndrome	0.000128	0.00154	CbGeAlD
Paclitaxel—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000124	0.00149	CbGeAlD
Paclitaxel—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000117	0.00141	CbGeAlD
Paclitaxel—TUBB6—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000116	0.0116	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000116	0.0116	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	0.000113	0.0113	CbGpPWpGaD
Paclitaxel—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000112	0.00136	CbGeAlD
Paclitaxel—TUBB3—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000112	0.0112	CbGpPWpGaD
Paclitaxel—BCL2—Validated targets of C-MYC transcriptional repression—CCL5—acquired immunodeficiency syndrome	0.00011	0.011	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000108	0.0109	CbGpPWpGaD
Paclitaxel—BCL2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000108	0.0109	CbGpPWpGaD
Paclitaxel—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000108	0.0013	CbGeAlD
Paclitaxel—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000107	0.00129	CbGeAlD
Paclitaxel—TUBB1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000106	0.0106	CbGpPWpGaD
Paclitaxel—BCL2—IL2 signaling events mediated by STAT5—IL2—acquired immunodeficiency syndrome	0.000103	0.0104	CbGpPWpGaD
Paclitaxel—ABCB1—blood—acquired immunodeficiency syndrome	0.000102	0.00123	CbGeAlD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.000101	0.0101	CbGpPWpGaD
Paclitaxel—ABCB1—bone marrow—acquired immunodeficiency syndrome	9.85e-05	0.00119	CbGeAlD
Paclitaxel—BCL2—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	9.83e-05	0.00986	CbGpPWpGaD
Paclitaxel—ABCB1—spinal cord—acquired immunodeficiency syndrome	9.81e-05	0.00118	CbGeAlD
Paclitaxel—SLCO1B3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	9.76e-05	0.00979	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	9.52e-05	0.00955	CbGpPWpGaD
Paclitaxel—ABCB1—vagina—acquired immunodeficiency syndrome	9.44e-05	0.00114	CbGeAlD
Paclitaxel—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	9.35e-05	0.00938	CbGpPWpGaD
Paclitaxel—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	9.19e-05	0.00922	CbGpPWpGaD
Paclitaxel—ABCB1—lung—acquired immunodeficiency syndrome	8.93e-05	0.00108	CbGeAlD
Paclitaxel—NR1I2—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	8.91e-05	0.00894	CbGpPWpGaD
Paclitaxel—BCL2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	8.74e-05	0.00877	CbGpPWpGaD
Paclitaxel—BCL2—IL2 signaling events mediated by PI3K—IL2—acquired immunodeficiency syndrome	8.73e-05	0.00876	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	8.71e-05	0.00874	CbGpPWpGaD
Paclitaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	8.43e-05	0.00846	CbGpPWpGaD
Paclitaxel—ABCB1—nervous system—acquired immunodeficiency syndrome	8.27e-05	0.000997	CbGeAlD
Paclitaxel—BCL2—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	8.2e-05	0.00823	CbGpPWpGaD
Paclitaxel—ABCB1—central nervous system—acquired immunodeficiency syndrome	7.96e-05	0.00096	CbGeAlD
Paclitaxel—BCL2—IL-2 Signaling Pathway—IL2—acquired immunodeficiency syndrome	7.89e-05	0.00791	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.66e-05	0.00768	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.66e-05	0.00768	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—IFNG—acquired immunodeficiency syndrome	7.26e-05	0.00728	CbGpPWpGaD
Paclitaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—acquired immunodeficiency syndrome	6.97e-05	0.00699	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	6.76e-05	0.00678	CbGpPWpGaD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.73e-05	0.000305	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000304	CcSEcCtD
Paclitaxel—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.7e-05	0.000304	CcSEcCtD
Paclitaxel—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.7e-05	0.000304	CcSEcCtD
Paclitaxel—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.7e-05	0.000304	CcSEcCtD
Paclitaxel—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.7e-05	0.000304	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.000304	CcSEcCtD
Paclitaxel—Cough—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000303	CcSEcCtD
Paclitaxel—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.68e-05	0.000303	CcSEcCtD
Paclitaxel—Constipation—Indinavir—acquired immunodeficiency syndrome	6.65e-05	0.000302	CcSEcCtD
Paclitaxel—Pain—Indinavir—acquired immunodeficiency syndrome	6.65e-05	0.000302	CcSEcCtD
Paclitaxel—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.64e-05	0.000301	CcSEcCtD
Paclitaxel—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.64e-05	0.000301	CcSEcCtD
Paclitaxel—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.64e-05	0.000301	CcSEcCtD
Paclitaxel—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000301	CcSEcCtD
Paclitaxel—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.62e-05	0.0003	CcSEcCtD
Paclitaxel—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.61e-05	0.0003	CcSEcCtD
Paclitaxel—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.61e-05	0.0003	CcSEcCtD
Paclitaxel—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.6e-05	0.000299	CcSEcCtD
Paclitaxel—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.59e-05	0.000299	CcSEcCtD
Paclitaxel—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000299	CcSEcCtD
Paclitaxel—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.58e-05	0.000298	CcSEcCtD
Paclitaxel—Nausea—Didanosine—acquired immunodeficiency syndrome	6.58e-05	0.000298	CcSEcCtD
Paclitaxel—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000298	CcSEcCtD
Paclitaxel—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.000298	CcSEcCtD
Paclitaxel—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.56e-05	0.000297	CcSEcCtD
Paclitaxel—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000297	CcSEcCtD
Paclitaxel—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.55e-05	0.000297	CcSEcCtD
Paclitaxel—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000297	CcSEcCtD
Paclitaxel—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.53e-05	0.000296	CcSEcCtD
Paclitaxel—Chest pain—Saquinavir—acquired immunodeficiency syndrome	6.52e-05	0.000296	CcSEcCtD
Paclitaxel—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.52e-05	0.000296	CcSEcCtD
Paclitaxel—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.52e-05	0.000296	CcSEcCtD
Paclitaxel—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000295	CcSEcCtD
Paclitaxel—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.5e-05	0.000295	CcSEcCtD
Paclitaxel—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.48e-05	0.000294	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.000294	CcSEcCtD
Paclitaxel—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.46e-05	0.000293	CcSEcCtD
Paclitaxel—BCL2—IL2-mediated signaling events—IL2—acquired immunodeficiency syndrome	6.45e-05	0.00647	CbGpPWpGaD
Paclitaxel—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.45e-05	0.000292	CcSEcCtD
Paclitaxel—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.42e-05	0.000291	CcSEcCtD
Paclitaxel—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.4e-05	0.000291	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.4e-05	0.00029	CcSEcCtD
Paclitaxel—Shock—Ritonavir—acquired immunodeficiency syndrome	6.39e-05	0.00029	CcSEcCtD
Paclitaxel—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.38e-05	0.00029	CcSEcCtD
Paclitaxel—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000289	CcSEcCtD
Paclitaxel—Cough—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000289	CcSEcCtD
Paclitaxel—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.38e-05	0.000289	CcSEcCtD
Paclitaxel—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.000289	CcSEcCtD
Paclitaxel—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000289	CcSEcCtD
Paclitaxel—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.36e-05	0.000288	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.36e-05	0.000288	CcSEcCtD
Paclitaxel—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.35e-05	0.000288	CcSEcCtD
Paclitaxel—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.000288	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000288	CcSEcCtD
Paclitaxel—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.000287	CcSEcCtD
Paclitaxel—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.33e-05	0.000287	CcSEcCtD
Paclitaxel—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.33e-05	0.000287	CcSEcCtD
Paclitaxel—ABCB1—brain—acquired immunodeficiency syndrome	6.32e-05	0.000762	CbGeAlD
Paclitaxel—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.31e-05	0.000286	CcSEcCtD
Paclitaxel—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.31e-05	0.000286	CcSEcCtD
Paclitaxel—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.31e-05	0.000286	CcSEcCtD
Paclitaxel—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.000285	CcSEcCtD
Paclitaxel—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.28e-05	0.000285	CcSEcCtD
Paclitaxel—Pain—Efavirenz—acquired immunodeficiency syndrome	6.28e-05	0.000285	CcSEcCtD
Paclitaxel—Rash—Nevirapine—acquired immunodeficiency syndrome	6.28e-05	0.000285	CcSEcCtD
Paclitaxel—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.27e-05	0.000285	CcSEcCtD
Paclitaxel—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.26e-05	0.000284	CcSEcCtD
Paclitaxel—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.26e-05	0.000284	CcSEcCtD
Paclitaxel—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.25e-05	0.000284	CcSEcCtD
Paclitaxel—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.25e-05	0.000283	CcSEcCtD
Paclitaxel—Headache—Nevirapine—acquired immunodeficiency syndrome	6.24e-05	0.000283	CcSEcCtD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—acquired immunodeficiency syndrome	6.22e-05	0.00624	CbGpPWpGaD
Paclitaxel—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.22e-05	0.000282	CcSEcCtD
Paclitaxel—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.22e-05	0.000282	CcSEcCtD
Paclitaxel—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.22e-05	0.000282	CcSEcCtD
Paclitaxel—Infection—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.000282	CcSEcCtD
Paclitaxel—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000281	CcSEcCtD
Paclitaxel—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.19e-05	0.000281	CcSEcCtD
Paclitaxel—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.18e-05	0.000281	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.00028	CcSEcCtD
Paclitaxel—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.00028	CcSEcCtD
Paclitaxel—Shock—Saquinavir—acquired immunodeficiency syndrome	6.15e-05	0.000279	CcSEcCtD
Paclitaxel—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.15e-05	0.000279	CcSEcCtD
Paclitaxel—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.14e-05	0.000279	CcSEcCtD
Paclitaxel—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.14e-05	0.000279	CcSEcCtD
Paclitaxel—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000278	CcSEcCtD
Paclitaxel—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.13e-05	0.000278	CcSEcCtD
Paclitaxel—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000278	CcSEcCtD
Paclitaxel—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.11e-05	0.000277	CcSEcCtD
Paclitaxel—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.11e-05	0.000277	CcSEcCtD
Paclitaxel—ABCB1—lymph node—acquired immunodeficiency syndrome	6.11e-05	0.000736	CbGeAlD
Paclitaxel—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000276	CcSEcCtD
Paclitaxel—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.08e-05	0.000276	CcSEcCtD
Paclitaxel—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.08e-05	0.000276	CcSEcCtD
Paclitaxel—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.07e-05	0.000276	CcSEcCtD
Paclitaxel—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000275	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000275	CcSEcCtD
Paclitaxel—Rash—Stavudine—acquired immunodeficiency syndrome	6.06e-05	0.000275	CcSEcCtD
Paclitaxel—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.06e-05	0.000275	CcSEcCtD
Paclitaxel—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.06e-05	0.000275	CcSEcCtD
Paclitaxel—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000275	CcSEcCtD
Paclitaxel—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.05e-05	0.000274	CcSEcCtD
Paclitaxel—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.04e-05	0.000274	CcSEcCtD
Paclitaxel—Headache—Stavudine—acquired immunodeficiency syndrome	6.02e-05	0.000273	CcSEcCtD
Paclitaxel—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.02e-05	0.000273	CcSEcCtD
Paclitaxel—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.02e-05	0.000273	CcSEcCtD
Paclitaxel—Pain—Delavirdine—acquired immunodeficiency syndrome	6.01e-05	0.000273	CcSEcCtD
Paclitaxel—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.01e-05	0.000273	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6e-05	0.000272	CcSEcCtD
Paclitaxel—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6e-05	0.000272	CcSEcCtD
Paclitaxel—Rash—Abacavir—acquired immunodeficiency syndrome	5.97e-05	0.000271	CcSEcCtD
Paclitaxel—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.97e-05	0.000271	CcSEcCtD
Paclitaxel—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.97e-05	0.000271	CcSEcCtD
Paclitaxel—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.97e-05	0.000271	CcSEcCtD
Paclitaxel—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.96e-05	0.00027	CcSEcCtD
Paclitaxel—Headache—Abacavir—acquired immunodeficiency syndrome	5.93e-05	0.000269	CcSEcCtD
Paclitaxel—Infection—Lamivudine—acquired immunodeficiency syndrome	5.93e-05	0.000269	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000269	CcSEcCtD
Paclitaxel—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.92e-05	0.000268	CcSEcCtD
Paclitaxel—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.91e-05	0.000268	CcSEcCtD
Paclitaxel—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.88e-05	0.000267	CcSEcCtD
Paclitaxel—Shock—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000266	CcSEcCtD
Paclitaxel—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.85e-05	0.000265	CcSEcCtD
Paclitaxel—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000265	CcSEcCtD
Paclitaxel—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000265	CcSEcCtD
Paclitaxel—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.83e-05	0.000265	CcSEcCtD
Paclitaxel—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000265	CcSEcCtD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	5.83e-05	0.00585	CbGpPWpGaD
Paclitaxel—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.8e-05	0.000263	CcSEcCtD
Paclitaxel—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.8e-05	0.000263	CcSEcCtD
Paclitaxel—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.79e-05	0.000263	CcSEcCtD
Paclitaxel—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.79e-05	0.000263	CcSEcCtD
Paclitaxel—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.79e-05	0.000263	CcSEcCtD
Paclitaxel—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.78e-05	0.000262	CcSEcCtD
Paclitaxel—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.77e-05	0.000262	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.75e-05	0.000261	CcSEcCtD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—acquired immunodeficiency syndrome	5.74e-05	0.00576	CbGpPWpGaD
Paclitaxel—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.73e-05	0.00026	CcSEcCtD
Paclitaxel—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.73e-05	0.00026	CcSEcCtD
Paclitaxel—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000259	CcSEcCtD
Paclitaxel—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.72e-05	0.000259	CcSEcCtD
Paclitaxel—Nausea—Stavudine—acquired immunodeficiency syndrome	5.71e-05	0.000259	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.000258	CcSEcCtD
Paclitaxel—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.69e-05	0.000258	CcSEcCtD
Paclitaxel—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.66e-05	0.000257	CcSEcCtD
Paclitaxel—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.65e-05	0.000256	CcSEcCtD
Paclitaxel—MAPT—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	5.64e-05	0.00565	CbGpPWpGaD
Paclitaxel—Nausea—Abacavir—acquired immunodeficiency syndrome	5.63e-05	0.000255	CcSEcCtD
Paclitaxel—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.62e-05	0.000255	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000254	CcSEcCtD
Paclitaxel—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.6e-05	0.000254	CcSEcCtD
Paclitaxel—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000253	CcSEcCtD
Paclitaxel—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.58e-05	0.000253	CcSEcCtD
Paclitaxel—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.58e-05	0.000253	CcSEcCtD
Paclitaxel—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000253	CcSEcCtD
Paclitaxel—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.56e-05	0.000252	CcSEcCtD
Paclitaxel—Pain—Ritonavir—acquired immunodeficiency syndrome	5.56e-05	0.000252	CcSEcCtD
Paclitaxel—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.56e-05	0.000252	CcSEcCtD
Paclitaxel—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.55e-05	0.000252	CcSEcCtD
Paclitaxel—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.55e-05	0.000252	CcSEcCtD
Paclitaxel—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.53e-05	0.000251	CcSEcCtD
Paclitaxel—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.5e-05	0.00025	CcSEcCtD
Paclitaxel—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.5e-05	0.000249	CcSEcCtD
Paclitaxel—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000247	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000247	CcSEcCtD
Paclitaxel—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.41e-05	0.000245	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000245	CcSEcCtD
Paclitaxel—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.4e-05	0.000245	CcSEcCtD
Paclitaxel—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.39e-05	0.000245	CcSEcCtD
Paclitaxel—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.36e-05	0.000243	CcSEcCtD
Paclitaxel—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.35e-05	0.000243	CcSEcCtD
Paclitaxel—Pain—Saquinavir—acquired immunodeficiency syndrome	5.35e-05	0.000243	CcSEcCtD
Paclitaxel—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.35e-05	0.000243	CcSEcCtD
Paclitaxel—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.32e-05	0.000241	CcSEcCtD
Paclitaxel—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.32e-05	0.000241	CcSEcCtD
Paclitaxel—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.31e-05	0.000241	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.31e-05	0.000241	CcSEcCtD
Paclitaxel—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.3e-05	0.000241	CcSEcCtD
Paclitaxel—Rash—Zidovudine—acquired immunodeficiency syndrome	5.27e-05	0.000239	CcSEcCtD
Paclitaxel—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.27e-05	0.000239	CcSEcCtD
Paclitaxel—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.26e-05	0.000239	CcSEcCtD
Paclitaxel—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.25e-05	0.000238	CcSEcCtD
Paclitaxel—Headache—Zidovudine—acquired immunodeficiency syndrome	5.24e-05	0.000238	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.23e-05	0.00525	CbGpPWpGaD
Paclitaxel—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.2e-05	0.000236	CcSEcCtD
Paclitaxel—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000235	CcSEcCtD
Paclitaxel—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.18e-05	0.000235	CcSEcCtD
Paclitaxel—BCL2—Ceramide signaling pathway—TNF—acquired immunodeficiency syndrome	5.16e-05	0.00518	CbGpPWpGaD
Paclitaxel—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000234	CcSEcCtD
Paclitaxel—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.15e-05	0.000234	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000234	CcSEcCtD
Paclitaxel—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.14e-05	0.000233	CcSEcCtD
Paclitaxel—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.14e-05	0.000233	CcSEcCtD
Paclitaxel—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000233	CcSEcCtD
Paclitaxel—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000233	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.11e-05	0.000232	CcSEcCtD
Paclitaxel—Pain—Lamivudine—acquired immunodeficiency syndrome	5.1e-05	0.000231	CcSEcCtD
Paclitaxel—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.1e-05	0.000231	CcSEcCtD
Paclitaxel—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.04e-05	0.000229	CcSEcCtD
Paclitaxel—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.02e-05	0.000228	CcSEcCtD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	5.01e-05	0.00502	CbGpPWpGaD
Paclitaxel—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.97e-05	0.000226	CcSEcCtD
Paclitaxel—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.97e-05	0.000225	CcSEcCtD
Paclitaxel—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.96e-05	0.000225	CcSEcCtD
Paclitaxel—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.94e-05	0.000224	CcSEcCtD
Paclitaxel—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.94e-05	0.000224	CcSEcCtD
Paclitaxel—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.94e-05	0.000224	CcSEcCtD
Paclitaxel—BCL2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	4.92e-05	0.00494	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.92e-05	0.00494	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.000223	CcSEcCtD
Paclitaxel—Rash—Indinavir—acquired immunodeficiency syndrome	4.9e-05	0.000222	CcSEcCtD
Paclitaxel—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.9e-05	0.000222	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000221	CcSEcCtD
Paclitaxel—Headache—Indinavir—acquired immunodeficiency syndrome	4.87e-05	0.000221	CcSEcCtD
Paclitaxel—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.86e-05	0.00022	CcSEcCtD
Paclitaxel—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.81e-05	0.000218	CcSEcCtD
Paclitaxel—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.79e-05	0.000217	CcSEcCtD
Paclitaxel—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000215	CcSEcCtD
Paclitaxel—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.000214	CcSEcCtD
Paclitaxel—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.000214	CcSEcCtD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	4.71e-05	0.00472	CbGpPWpGaD
Paclitaxel—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.67e-05	0.000212	CcSEcCtD
Paclitaxel—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.66e-05	0.000211	CcSEcCtD
Paclitaxel—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.65e-05	0.000211	CcSEcCtD
Paclitaxel—Rash—Efavirenz—acquired immunodeficiency syndrome	4.63e-05	0.00021	CcSEcCtD
Paclitaxel—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.63e-05	0.00021	CcSEcCtD
Paclitaxel—Nausea—Indinavir—acquired immunodeficiency syndrome	4.62e-05	0.000209	CcSEcCtD
Paclitaxel—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.61e-05	0.000209	CcSEcCtD
Paclitaxel—Headache—Efavirenz—acquired immunodeficiency syndrome	4.6e-05	0.000209	CcSEcCtD
Paclitaxel—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.6e-05	0.000209	CcSEcCtD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—TNF—acquired immunodeficiency syndrome	4.5e-05	0.00451	CbGpPWpGaD
Paclitaxel—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.49e-05	0.000204	CcSEcCtD
Paclitaxel—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.47e-05	0.000203	CcSEcCtD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	4.45e-05	0.00446	CbGpPWpGaD
Paclitaxel—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.45e-05	0.000202	CcSEcCtD
Paclitaxel—Rash—Delavirdine—acquired immunodeficiency syndrome	4.43e-05	0.000201	CcSEcCtD
Paclitaxel—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.43e-05	0.000201	CcSEcCtD
Paclitaxel—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.42e-05	0.000201	CcSEcCtD
Paclitaxel—Headache—Delavirdine—acquired immunodeficiency syndrome	4.4e-05	0.0002	CcSEcCtD
Paclitaxel—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.4e-05	0.000199	CcSEcCtD
Paclitaxel—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.36e-05	0.000198	CcSEcCtD
Paclitaxel—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.3e-05	0.000195	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	4.29e-05	0.0043	CbGpPWpGaD
Paclitaxel—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000194	CcSEcCtD
Paclitaxel—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.28e-05	0.000194	CcSEcCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	4.26e-05	0.00428	CbGpPWpGaD
Paclitaxel—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.22e-05	0.000191	CcSEcCtD
Paclitaxel—BCL2—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	4.21e-05	0.00423	CbGpPWpGaD
Paclitaxel—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.17e-05	0.000189	CcSEcCtD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	4.14e-05	0.00415	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	4.14e-05	0.00415	CbGpPWpGaD
Paclitaxel—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.14e-05	0.000188	CcSEcCtD
Paclitaxel—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.13e-05	0.000187	CcSEcCtD
Paclitaxel—Rash—Ritonavir—acquired immunodeficiency syndrome	4.1e-05	0.000186	CcSEcCtD
Paclitaxel—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.09e-05	0.000186	CcSEcCtD
Paclitaxel—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000185	CcSEcCtD
Paclitaxel—Headache—Ritonavir—acquired immunodeficiency syndrome	4.07e-05	0.000185	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	4.04e-05	0.00405	CbGpPWpGaD
Paclitaxel—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.98e-05	0.00018	CcSEcCtD
Paclitaxel—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.95e-05	0.000179	CcSEcCtD
Paclitaxel—Rash—Saquinavir—acquired immunodeficiency syndrome	3.94e-05	0.000179	CcSEcCtD
Paclitaxel—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.94e-05	0.000179	CcSEcCtD
Paclitaxel—Headache—Saquinavir—acquired immunodeficiency syndrome	3.92e-05	0.000178	CcSEcCtD
Paclitaxel—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.86e-05	0.000175	CcSEcCtD
Paclitaxel—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.79e-05	0.000172	CcSEcCtD
Paclitaxel—Rash—Lamivudine—acquired immunodeficiency syndrome	3.76e-05	0.000171	CcSEcCtD
Paclitaxel—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.76e-05	0.00017	CcSEcCtD
Paclitaxel—Headache—Lamivudine—acquired immunodeficiency syndrome	3.74e-05	0.00017	CcSEcCtD
Paclitaxel—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.71e-05	0.000169	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.71e-05	0.00373	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.7e-05	0.00371	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.59e-05	0.0036	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.58e-05	0.00359	CbGpPWpGaD
Paclitaxel—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.54e-05	0.000161	CcSEcCtD
Paclitaxel—BCL2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	3.53e-05	0.00354	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	3.32e-05	0.00333	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	3.3e-05	0.00331	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TNF—acquired immunodeficiency syndrome	3.29e-05	0.0033	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.24e-05	0.00325	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.24e-05	0.00325	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	3.08e-05	0.00309	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.78e-05	0.00279	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	2.74e-05	0.00275	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.72e-05	0.00273	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.72e-05	0.00273	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.64e-05	0.00265	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	2.6e-05	0.00261	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.58e-05	0.00259	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	2.58e-05	0.00259	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.38e-05	0.00238	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ACTG1—acquired immunodeficiency syndrome	2.35e-05	0.00236	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	2.34e-05	0.00235	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.33e-05	0.00234	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	2.23e-05	0.00223	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	2.19e-05	0.0022	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	2.02e-05	0.00203	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.02e-05	0.00203	CbGpPWpGaD
Paclitaxel—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.01e-05	0.00201	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.95e-05	0.00195	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	1.94e-05	0.00194	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MBL2—acquired immunodeficiency syndrome	1.93e-05	0.00194	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	1.87e-05	0.00188	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.85e-05	0.00185	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	1.76e-05	0.00177	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.71e-05	0.00172	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	1.7e-05	0.00171	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	1.69e-05	0.00169	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.65e-05	0.00166	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.65e-05	0.00165	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.64e-05	0.00165	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.6e-05	0.0016	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.59e-05	0.0016	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	1.57e-05	0.00158	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CCR2—acquired immunodeficiency syndrome	1.52e-05	0.00152	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.5e-05	0.00151	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.5e-05	0.00151	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.45e-05	0.00146	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.45e-05	0.00145	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	1.44e-05	0.00144	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.42e-05	0.00142	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.41e-05	0.00141	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.37e-05	0.00138	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNA1—acquired immunodeficiency syndrome	1.37e-05	0.00137	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD79A—acquired immunodeficiency syndrome	1.33e-05	0.00133	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.23e-05	0.00124	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.22e-05	0.00123	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.13e-05	0.00113	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.08e-05	0.00108	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.07e-05	0.00108	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—acquired immunodeficiency syndrome	1.07e-05	0.00107	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CSF2—acquired immunodeficiency syndrome	1.07e-05	0.00107	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.06e-05	0.00106	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.05e-05	0.00106	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	1.04e-05	0.00104	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.03e-05	0.00104	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.03e-05	0.00103	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.02e-05	0.00102	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.01e-05	0.00101	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	9.21e-06	0.000924	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	8.99e-06	0.000902	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	8.61e-06	0.000864	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	8.26e-06	0.000828	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.83e-06	0.000786	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.62e-06	0.000764	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.58e-06	0.000761	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.34e-06	0.000736	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.32e-06	0.000734	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.3e-06	0.000732	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.21e-06	0.000723	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNG—acquired immunodeficiency syndrome	6.35e-06	0.000638	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.35e-06	0.000637	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—acquired immunodeficiency syndrome	6.14e-06	0.000616	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.7e-06	0.000572	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	5.68e-06	0.00057	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	5.66e-06	0.000568	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—acquired immunodeficiency syndrome	5.65e-06	0.000567	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.1e-06	0.000512	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.83e-06	0.000484	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	4.78e-06	0.000479	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	4.5e-06	0.000451	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.14e-06	0.000415	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	3.55e-06	0.000357	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.43e-06	0.000344	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.39e-06	0.00034	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	3.38e-06	0.000339	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.37e-06	0.000338	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—acquired immunodeficiency syndrome	3.32e-06	0.000333	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	3.27e-06	0.000328	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	2.97e-06	0.000298	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.95e-06	0.000296	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	2.13e-06	0.000214	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	1.92e-06	0.000193	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.84e-06	0.000185	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.61e-06	0.000161	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.5e-06	0.000151	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	9.9e-07	9.93e-05	CbGpPWpGaD
